Heat-responsive gene expression for gene therapy

Advanced Drug Delivery Reviews

Volumn 61, Issue 7-8, 2009, Pages 641-649

  Walther, Wolfgang ^a   Stein, Ulrike ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cancer therapy; Gene therapy; Heat inducible; Heat shock; Hyperthermia; Promoter

Indexed keywords

CANCER THERAPY; GENE THERAPY; HEAT-INDUCIBLE; HEAT-SHOCK; HYPERTHERMIA; PROMOTER;

BIOACTIVITY; CHEMOTHERAPY; GENE EXPRESSION; GENETIC ENGINEERING;

HYPERTHERMIA THERAPY;

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CYTOSINE DEAMINASE; DOXORUBICIN; FLUCYTOSINE; GANCICLOVIR; GLYCOGEN SYNTHASE KINASE 3ALPHA; GREEN FLUORESCENT PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70B; HEAT SHOCK PROTEIN 90; HEAT SHOCK TRANSCRIPTION FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 2; MANGANESE ZINC FERRITE NANOPARTICLE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOPHENOL MONOOXYGENASE; MULTIDRUG RESISTANCE PROTEIN 1; NANOPARTICLE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C LAMBDA; STRESS ACTIVATED PROTEIN KINASE; TELOMERASE REVERSE TRANSCRIPTASE; THYMIDINE KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER GENE THERAPY; CYTOMEGALOVIRUS; DRUG EFFICACY; EXPRESSION VECTOR; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE VECTOR; GLIOMA; HEAT RESPONSIVE CANCER GENE THERAPY; HEAT SHOCK; HUMAN; HYPERTHERMIA; MELANOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SOFT TISSUE SARCOMA; SUICIDE GENE; TRANSGENE;

ANIMALS; FEVER; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HEAT-SHOCK PROTEINS; HUMANS; HYPERTHERMIA, INDUCED;

EID: 65749098039     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2009.02.009     Document Type: Review

References (84)

1. Miller N., and Whealan J. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum. Gene Ther. 8 (1997) 803-815
2. Varley A.W., and Munford R.S. Physiologically responsive gene therapy. Mol. Med. Today 4 (1998) 445-451
3. Walther W., and Stein U. Cell type specific and inducible promoters for vectors in gene therapy as an approach for cell targeting. J. Mol. Med. 74 (1996) 379-392
4. Hallahan D.E., Mauceri H.J., Seung L.P., Dunphy E.J., Wayne J.D., Hanna N.N., Toledano A., Hellman S., Kufe D.W., and Weichselbaum R.R. Spatial and temporal control of gene therapy using ionizing radiation. Nat. Med. 1 (1995) 786-791
5. Walther W., Wendt J., and Stein U. Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy. Gene Ther. 4 (1997) 544-552
6. Blackburn R.V., Galoforo S.S., Corry P.M., and Lee Y.J. Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells. Cancer Res. 58 (1998) 1358-1362
7. Sherar M., Liu F.F., Pintilie M., Levin W., Hunt J., Hill R., Hand J., Vernon C., van Rhoon G., vn der Zee J., Gonzalez D.G., Van Dijk J., Whaley J., and Machin D. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 39 (1997) 371-380
8. Hildebrandt B., Wust P., Rau B., Schlag P.M., and Riess H. Regional hyperthermia for rectal cancer. Lancet 356 (2000) 771-772
9. Rau B., Wust P., Tilly W., Gellermann J., Harder C., Riess H., Budach V., Felix R., and Schlag P.M. Preoperative radio-chemotherapy in locally advanced recurrent rectal cancer: regional radiofrequency hyperthermia correlates with clinical parameters. Int. J. Radiat. Oncol. Phys. 48 (2000) 381-391
10. Wust P., Hildebrandt B., Sreenivasa G., Rau B., Gellermann J., Riess H., Felix R., and Schlag P.M. Hyperthermia in combined treatment of cancer. Lancet Oncol. 3 (2002) 487-497
11. Dewhirst M.W., Prosnitz L., and Thrall D. Hyperthermic treatment of malignant diseases: current status and a view toward the future. Sem. Oncol. 24 (1997) 616-625
12. Schweinfest C.W., Jorcyk C.L., Fujiwara S., and Papas T.S. A heat-shock-inducible eucaryotic expression vector. Gene 71 (1988) 207-210
13. Huang Q., Hu J.K., Lohr F., Zhang L., Braun R., Lanzen J., Little J.B., Dewhirst M.W., and Li C.Y. Heat-induced expression as a novel targeted cancer gene therapy strategy. Cancer Res. 60 (2000) 3435-3439
14. Luna M.C., Ferrarion A., Wong S., Fisher A.M.R., and Gomer C.J. Photodynamic therapy-mediated oxidative stress as a molecular switch for the temporal expression of genes ligated to the human heat shock promoter. Cancer Res. 60 (2000) 1637-1644
15. Gerner E.W., Hersh E.M., Pennington M., Tsang T.C., Harris D., Vasanwala F., and Brailey J. Heat-inducible vectors for use in gene therapy. Int. J. Hyperthermia 16 (2000) 171-181
16. Brade A.M., Ngo D., Szmitko P., Li P.X., Liu F.F., and Klamut H.J. Heat-directed gene targeting of adenoviral vectors to tumor cells. Cancer Gene Ther. 12 (2000) 1566-1574
17. Lindquist S. The heat-shock response. Annu. Rev. Biochem. 55 (1986) 1151-1191
18. Kühl N.M., and Rensing L. Heat shock effects on cell cycle progression. Cell. Mol. Life Sci. 57 (2000) 450-463
19. Sonna L.A., Fujita J., Gaffin S.L., and Lilly C.M. Invited review: effects of heat and cold stress on mammalian gene expression. J. Appl. Physiol. 92 (2002) 1725-1742
20. Parsell D.A., and Lindquist S. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu. Rev. Genet. 27 (1993) 437-496
21. Otterbein L.E., and Choi A.M. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol. Lung Cell Mol. Physiol. 279 (2000) L1029-1037
22. Morimoto R.I. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev. 12 (1998) 3788-3796
23. Morano K.A., and Thiele D.J. Heat shock factor function and regulation in response to cellular stress, growth, and differentiation signals. Gene Expr. 7 (1999) 271-282
24. Cotto J.J., Kline M., and Morimoto R.I. Activation of heat shock factor 1 DNA binding precedes stress-induced serine phosphorylation. Evidence for a multistep pathway of regulation. J. Biol. Chem. 271 (1996) 3355-3358
25. Chu B., Zhong R., Soncin F., Stevenson M.A., and Calderwood S.K. Transcriptional activity of heat shock factor 1 at 37 degrees C is repressed through phosphorylation on two distinct serine residues by glycogen synthase kinase 3 and protein kinases Calpha and Czeta. J. Biol. Chem. 273 (1998) 18640-18646
26. Holmberg C.I., Hietakangas V., Mikhailov A., Rantanen J.O., Kallio M., Meinander A., Hellman J., Morrice N., MacKintosh C., Morimoto R.I., Eriksson J.E., and Sistonen L. Phosphorylation of serine 230 promotes inducible transcriptional activity of heat shock factor 1. EMBO J. 20 (2001) 3800-3810
27. Guettouche T., Boellmann F., Lane W.S., and Voellmy R. Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress. BMC Biochem. 11 (2005) 4
28. Wang Y., and Morgan W.D. Cooperative interaction of human HSF1 heat shock transcription factor with promoter DNA. Nucleic Acids Res. 22 (1994) 3113-3118
29. Dewey W.C. Arrhenius relationships from the molecule and cell to the clinic. Int. J. Hyperthermia. 10 (1994) 457-483
30. Steeves R.A. A brief history of radiation therapy and recent progress in hyperthermia. Wis. Med. J. 82 (1983) 16-17
31. Grünhagen D.J., de Wilt J.H., ten Hagen T.L., and Eggermont A.M. Technology insight: Utility of TNF-alpha-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities. Nat. Clin. Pract. Oncol. 3 (2006) 94-103
32. Kerner T., Deja M., Ahlers O., Löffel J., Hildebrandt B., Wust P., Gerlach H., and Riess H. Whole body hyperthermia: a secure procedure for patients with various malignancies?. Intensive Care Med. 25 (1999) 959-965
33. van der Zee J. Heating the patient: a promising approach?. Annals Oncol. 13 (2004) 1173-1184
34. Moyer H.R., and Delman K.A. The role of hyperthermia in optimizing tumor response to regional therapy. Int. J. Hyperthermia 24 (2008) 251-261
35. Milner C.M., and Campbell R.D. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 32 (1990) 242-251
36. Voellmy R., Ahmed A., Schiller P., Bromley P., and Rungger D. Isolation and functional analysis of a human 70,000-dalton heat shock protein gene segment. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 4949-4953
37. Schiller P., Amin J., Ananthan J., Brown M.E., Scott W.A., and Voellmy R. Cis-acting elements involved in the regulated expression of a human HSP70 gene. J. Mol. Biol. 203 (1988) 97-105
38. Leung T.K., Rajendran M.Y., Monfries C., Hall C., and Lim L. The human heat-shock protein family. Expression of a novel heat-inducible HSP70 (HSP70B′) and isolation of its cDNA and genomic DNA. Biochem. J. 267 (1990) 125-132
39. Parsian A.J., Sheren J.E., Tao T.Y., Goswami P.C., Malyapa R., Van Rheeden R., Watson M.S., and Hunt C.R. The human Hsp70B gene at the HSPA7 locus of chromosome 1 is transcribed but non-functional. Biochim. Biophys. Acta. 1494 (2000) 201-205
40. Rohmer S., Mainka A., Knippertz I., Hesse A., and Nettelbeck D.M. Insulated hsp70B′ promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses. J. Gene Med. 10 (2008) 340-354
41. Morgan W.D., Williams G.T., Morimoto R.I., Greene J., Kingston R.E., and Tjian R. Two transcriptional activators, CCAAT-box-binding transcription factor and heat shock transcription factor, interact with the human hsp70 gene promoter. Mol. Cell. Biol. 7 (1987) 1129-1138
42. Cunniff N.F.A., and Morgan W.D. Analysis of heat shock element recognition by saturation mutagenesis of the human HSP70.1 gene promoter. J. Biol. Chem. 268 (1993) 8317-8324
43. Braiden V., Ohtsuru A., Kawashita Y., Miki F., Sawada T., Ito M., Cao Y., Kaneda Y., Koji T., and Yamashita S. Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter. Hum Gene Ther. 11 (2000) 2453-2463
44. Guilhon E., Voisin P., de Zwart J.A., Quesson B., Salomir R., Maurange C., Bouchaud V., Smirnov P., de Verneuil H., Vekris A., Canioni P., and Moonen C.T. Spatial and temporal control of transgene expression in vivo using a heat-sensitive promoter and MRI-guided focused ultrasound. J. Gene Med. 5 (2003) 333-342
45. Xu L., Zhao Y., Zhang Q., Li Y., and Xu Y. Regulation of transgene expression in muscles by ultrasound-mediated hyperthermia. Gene Ther. 11 (2004) 894-900
46. Brade A.M., Szmitko P., Ngo D., Liu F.F., and Klamut H.J. Heat-directed suicide gene therapy for breast cancer. Cancer Gene Ther. 10 (2003) 294-301
47. Lohr F., Hu K., Huang Q., Zhang L., Samulski T.V., Dewhirst M.W., and Li C.Y. Enhancement of radiotherapy by hyperthermia-regulated gene therapy. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 1513-1518
48. Siddiqui F., Li C.Y., Larue S.M., Poulson J.M., Avery P.R., Pruitt A.F., Zhang X., Ullrich R.L., Thrall D.E., Dewhirst M.W., and Hauck M.L. A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas. Mol. Cancer Ther. 6 (2007) 380-389
49. Vekris A., Maurange C., Moonen C., Mazurier F., De Verneuil H., Canioni P., and Voisin P. Control of transgene expression using local hyperthermia in combination with a heat-sensitive promoter. J. Gene Med. 2 (2000) 89-96
50. Borrelli M.J., Schoenherr D.M., Wong A., Bernock L.J., and Corry P.M. Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells. Cancer Res. 61 (2001) 1113-1121
51. Pirkkala L., Nykänen P., and Sistonen L. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J. 15 (2001) 1118-1131
52. Siddiqui F., Avery P.R., Li C.Y., Zhang X., LaRue S.M., Dewhirst M.W., and Ullrich R.L. Induction of the human heat shock promoter HSP70B by nutritional stress: implications for cancer gene therapy. Cancer Invest. 26 (2008) 553-561
53. Luo P., He X., Tsang T.C., and Harris D.T. A novel inducible amplifier expression vector for high and controlled gene expression. Int. J. Mol. Med. 13 (2004) 319-325
54. Wang J., Yao M., Zhang Z., Gu J., Zhang Y., Li B., Sun L., and Liu X. Enhanced suicide gene therapy by chimeric tumor-specific promoter based on HSF1 transcriptional regulation. FEBS Lett. 546 (2003) 315-320
55. Emiliusen L., Gough M., Bateman A., Ahmed A., Voellmy R., Chester J., Diaz R.M., Harrington K., and Vile R. A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component. Gene Ther. 8 (2001) 987-998
56. Luethy J.D., Fargnoli J., Park J.S., Fornace Jr. A.J., and Holbrook N.J. Isolation and characterization of the hamster gadd153 gene. Activation of promoter activity by agents that damage DNA. J. Biol. Chem. 265 (1990) 16521-16526
57. Luethy J.D., and Holbrook N.J. Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res. 52 (1992) 5-10
58. Delmastro D.A., Li J., Vaisman A., Solle M., and Chaney S.G. DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines. Cancer Chemother Pharmacol. 39 (1997) 245-253
59. Bouhon I.A., Ito A., Shinkai M., Honda H., and Kobayashi T. Heat induction of reporter gene expression via the gadd153 promoter and its possible application hyperthermia treatment of cancer. Cytotechnol 33 (2000) 131-137
60. Ito A., Shinkai M., Bouhon I.A., Honda H., and Kobayashi T. Induction of TNF-a gene expression by heat inducible promoter gadd153. Jpn. J. Hyperthermic Oncol. 16 (2000) 91-98
61. Ito A., Shinkai M., Bouhon I.A., Honda H., and Kobayashi T. Bystander-killing effect and cyclic induction of TNF-a gene under heat-inducible promoter gadd 153. J. Biosci. Bioeng. 90 (2000) 437-441
62. Ito A., Shinkai M., Honda H., and Kobayashi T. Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy. Cancer Gene Ther. 8 (2001) 649-654
63. Chin K.-V., Tanaka S., Darlington G., Pastan I., and Gottesmann M.M. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 265 (1990) 221-226
64. Uchiumi T., Kohno K., Tanimura H., Hidaka K., Asakuno K., Abe H., Uchida Y., and Kuwano M. Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter. FEBS Lett. 326 (1993) 11-16
65. Kohno K., Sato S., Takano H., Matsuo K., and Kuwano M. The direct activation of human multidrug resistance gene (MDR1). Biochem. Biophys. Res. Comm. 165 (1989) 1415-1421
66. Stein U., Walther W., and Wunderlich V. Point mutations in the mdr1 promoter region of human osteosarcomas are related with responsiveness to MDR relevant drugs. Eur. J. Cancer 30A (1994) 1541-1545
67. Stein U., Walther W., and Shoemaker R.H. Vincristine induction of mutant and wildtype human multidrug-resistance promoters is cell type-specific and dose-dependent. J. Cancer Res. Clin. Oncol. 122 (1996) 275-282
68. Walther W., Stein U., Fichtner I., Alexander M., Shoemaker R.H., and Schlag P.M. Mdr1 promoter driven TNFa-expression for a chemotherapy-controllable combined in vivo gene- and chemotherapy of tumors. Cancer Gene Ther. 7 (2000) 893-900
69. Kioka N., Yamano Y., Komano T., and Ueda K. Heat-shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett. 301 (1992) 37-40
70. Vilaboa N.E., Galán A., Troyano A., de Blas E., and Aller P. Regulation of multidrug resistance (MDR1)/P-glycoprotein gene expression and activity by heat-shock transcription factor 1 (HSF1). J. Biol. Chem. 275 (2000) 24970-24976
71. Miyazaki M., Kohno K., Uchiumi T., Tanimura H., Matsuo K., Nasu M., and Kuwano M. Activation of human multidrug resistance-1 gene promoter in response to heat shock stress. Biochem. Biophys. Res. Comm. 187 (1992) 677-684
72. Kim S.-H., Hur W.-Y., Kang C.-D., Lim Y.-S., Kim D.-W., and Chung B.-S. Involvement of heat shock factor in regulating transcriptional activation of MDR1 gene in multidrug-resistant cells. Cancer Lett. 115 (1997) 9-14
73. Scotto K. Transcriptional regulation of ABC drug transporters. Oncogene 22 (2003) 7496-7511
74. Walther W., Stein U., and Schlag P.M. Use of the mdr1 promoter for heat-inducible expression of therapeutic genes. Int. J. Cancer 98 (2002) 291-296
75. Walther W., Arlt F., Stein U., Fichtner I., and Schlag P.M. Heat-inducible in vivo gene therapy of colon carcinoma by human mdr1 promoter regulated TNF-α expression. Mol. Cancer Ther. 6 (2007) 235-243
76. Stein U., Jürchott K., Walther W., Bergmann S., Schlag P.M., and Royer H.-D. Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters. J. Biol. Chem. 276 (2001) 28562-28569
77. Lee Y.J., Kim J.H., and Ryu S. Comparison of heat shock gene expression in mild-hyperthermia sensitive human prostatic carcinoma cells and heat-resistant human breast carcinoma cells. J. Therm. Biol. 19 (1994) 151-161
78. Lee Y.J., Hou Z.-Z., Curetti L.L., Erdos G., Stromberg J.S., Carper S.W., Cho J.M., and Corry P.M. Regulation of HSP70 and HSP28 gene expression: absence of compensatory mechanisms. Mol. Cell. Biochem. 137 (1994) 155-167
79. Lee Y.J., Lee H., and Borelli M.J. Gene transfer into human prostate adenocarcinoma cells with an adenoviral vector: hyperthermia enhances a double suicide gene expression, cytotoxicity and radiotoxicity. Cancer Gene Ther. 9 (2002) 267-274
80. Kobelt D., Aumann J., Bölling O., Fichtner I., Lemm M., Stein U., Schlag P.M., and Walther W. Heat inducibility of the human cytomegolovirus (CMV) immediate-early promoter: identification of possible mechanism. Eur. J. Med. Res. 12 Suppl. IV (2007) 27
81. Xu L., Zhao Y., Zhang Q., Li Y., and Xu Y. Regulation of transgene expression in muscles by ultrasound-mediated hyperthermia. Gene Ther. 11 (2004) 894-900
82. Guilhon E., Quesson B., Moraud-Gaudry F., de Verneuil H., Canioni P., Salomir R., Voisin P., and Moonen C.T. Image-guided control of transgene expression based on local hyperthermia. Mol. Imaging 2 (2003) 11-17
83. Yanase M., Shinkai M., Honda H., Wakabayashi T., Yoshida J., and Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. Jpn. J. Cancer Res. 89 (1998) 463-469
84. Tang Q.S., Zhang D.S., Cong X.M., Wan M.L., and Jin L.Q. Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression. Biomaterials 29 (2008) 2673-2679